Details of the Drug

General Information of Drug (ID: DMB0LSF)

Drug Name

ALMB-0168

Indication

Disease Entry	ICD 11	Status	REF
Osteosarcoma	2B51	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Gap junction alpha-1 protein (GJA1)	TT4F7SL	CXA1_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04886765) A Phase I/II, Multi-center, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of AlaMab Therapeutics